Lise Hoffmann

Lise Hoffmann has extensive experience in the regulatory affairs field, currently serving as the Regulatory Affairs Program Director at Novo Nordisk since December 2008. Prior roles at Novo Nordisk include Regulatory Principal Specialist, Senior Global Regulatory Lead, Global Regulatory Lead, Senior Regulatory Professional, and Regulatory Professional. Lise's earlier career includes positions as a Research Scientist at Novozymes A/S, Principal Scientist at CMC Biopharmaceuticals A/S, and Research Scientist at Dako Denmark A/S, alongside postdoctoral and doctoral research at Carlsberg A/S and Rigshospitalet, respectively. Lise holds a Master’s and Ph.D. in Molecular Genetics (Biochemistry) from Københavns Universitet - University of Copenhagen.